Suppr超能文献

Harmonic 设备在肿瘤外科中的应用:证据的伞式综述。

Performance of Harmonic devices in surgical oncology: an umbrella review of the evidence.

机构信息

Ethicon Inc, 4545 Creek Rd, Cincinnati, OH, 45242, USA.

Cornerstone Research Group, 3228 South Service Road, Suite 204, Burlington, Ontario, L7N 3H8, Canada.

出版信息

World J Surg Oncol. 2018 Jan 4;16(1):2. doi: 10.1186/s12957-017-1298-x.

Abstract

BACKGROUND

We performed an umbrella review of systematic reviews summarizing the evidence on the Harmonic scalpel (HS) compared with conventional techniques in surgical oncology (including lymph node dissection).

METHODS

We searched MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews from inception to end of March of 2017 for meta-analyses or systematic reviews of randomized trials comparing HS to conventional techniques in surgical oncology. We assessed the quality of included systematic reviews with AMSTAR (A MeaSurement Tool to Assess systematic Reviews) and assessed the certainty in evidence for each pooled outcome using GRADE (Grading of Recommendations Assessment, Development, and Evaluation).

RESULTS

We identified ten systematic reviews on breast cancer (n = 3), gastric cancers (n = 3), oral, head, and neck cancers (n = 1), and colon cancers (n = 3). Most reviews received a higher rating using AMSTAR. For operative time, systematic reviews reported a reduction of 25 to 29 min for HS compared with conventional methods across oncology types, with the exception of breast cancer where little differences were observed (very low to moderate quality of evidence (GRADE)). For blood loss and drainage volume, the majority of reviews reported statistically significant reductions with HS, and reductions ranged from 42 to 141 mL, and from 42 to 292 mL, respectively (very low to moderate quality of evidence). Hospitalization days were reported to decrease with use of HS by 0.2 to 3.2 days; however, reductions were only statistically significant for half of the included reviews (low to moderate quality of evidence). Regarding perioperative complications, two of six reviews reported a significantly reduced risk with HS use (breast cancer surgery) (moderate to high quality evidence)).

CONCLUSION

Across surgical oncology types, the majority of included systematic reviews showed a statistically significant or numerical improvement in surgical outcomes with use of the HS compared with conventional methods. Well-designed randomized studies with large sample sizes will help to provide more precise estimates and reduce the risk of heterogeneity.

摘要

背景

我们对系统评价进行了伞式评价,总结了在外科肿瘤学(包括淋巴结清扫术)中使用 Harmonic scalpel(HS)与传统技术相比的证据。

方法

我们从 MEDLINE、EMBASE 和 Cochrane 系统评价数据库中检索了截至 2017 年 3 月底的比较 HS 与传统技术在外科肿瘤学中的 meta 分析或系统评价。我们使用 AMSTAR(一种评估系统评价的测量工具)评估纳入系统评价的质量,并使用 GRADE(推荐评估、制定和评估分级)评估每个汇总结果的证据确定性。

结果

我们确定了 10 项关于乳腺癌(n=3)、胃癌(n=3)、口腔、头颈部和结肠癌(n=3)的系统评价。大多数综述使用 AMSTAR 获得了更高的评分。对于手术时间,系统评价报告 HS 与传统方法相比,在所有肿瘤类型中减少了 25 至 29 分钟,除了乳腺癌,差异很小(证据质量为极低至中度(GRADE))。对于出血量和引流量,大多数综述报告 HS 具有统计学意义的减少,减少范围分别为 42 至 141ml 和 42 至 292ml(证据质量为极低至中度)。使用 HS 可减少 0.2 至 3.2 天的住院天数;然而,只有一半的纳入综述报告减少具有统计学意义(证据质量为低至中度)。关于围手术期并发症,有 6 项综述中的 2 项报告 HS 使用可显著降低风险(乳腺癌手术)(证据质量为中至高))。

结论

在所有外科肿瘤类型中,大多数纳入的系统评价显示,与传统方法相比,使用 HS 可在手术结果方面取得统计学意义上或数值上的改善。具有大样本量的精心设计的随机研究将有助于提供更精确的估计并降低异质性风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e620/5755263/c2b043702e33/12957_2017_1298_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验